| Date Filed | Type | Description |
| 06/05/2023 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Sold 5,000 shares
@ $64.24, valued at
$321.2k
Exercised 5,000 options to buy
@ $37.29, valued at
$186.5k
|
|
| 03/27/2023 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Granted 1 options to buy
@ $0
Granted 2 options to buy
@ $0 |
|
| 03/01/2023 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Sold 7,000 shares
@ $49.27, valued at
$344.9k
Exercised 7,000 options to buy
@ $30, valued at
$210k
|
|
| 12/13/2022 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Granted 593 shares
@ $0
Granted 3,209 options to buy
@ $47.19, valued at
$151.4k
|
|
| 12/05/2022 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Granted 2 options to buy
@ $0 |
|
| 09/12/2022 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Granted 1 options to buy
@ $0 |
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Granted 1 options to buy
@ $0 |
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Granted 7,500 options to buy
@ $37.29, valued at
$279.7k
|
|
| 05/21/2020 |
4
| Ross Bridget A (Director) has filed a Form 4 on LEMAITRE VASCULAR INC|
Txns:
| Acquired 20,000 options to buy
@ $30, valued at
$600k
Disposed of 20,000 options to buy
@ $30, valued at
$600k
Granted 20,000 options to buy
@ $30, valued at
$600k
|
|
| 05/08/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |